Arrivent Biopharma, Inc To Start Trading Tomorrow

ArriVent BioPharma, Inc AVBP IPO will take place January, 26 on the NASDAQ exchange under the ticker AVBP.

The company is offering shares at an expected price between $17.00 and $19.00 per share with an insider lock-up period of 180 days ending on July 24, 2024.

See also: Benzinga IPO Calendar

About ArriVent BioPharma, Inc

ArriVent BioPharma, Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.